Is Optum Real For Real?

Providers increasingly accuse payers of delaying and denying reimbursement for claims. Now, UnitedHealth Group’s Optum subsidiary is hoping to change the dynamic through what they claim is a real-time claims management program leveraging tech. The post Is Optum Real For Real? appeared first on MedCity News.

Read More

Ventyx Bio Cardiovascular Drug’s Phase 2 Results Set Up Talks With a Big Pharma Firm

In a placebo-controlled mid-stage study, Ventyx Biosciences’ oral NLRP3 inhibitor led to rapid and sustained reductions in levels of a protein that’s an indicator of cardiovascular disease risk. The brain-penetrating properties of this once-daily pill also have potential applications addressing inflammation that drives neurodegenerative disorders. The post Ventyx Bio Cardiovascular Drug’s Phase 2 Results Set…

Read More

KFF/Washington Post Poll Looks at Parents’ Trust in Children’s Health Content on Social Media, And Unfounded Claims About Abortion Pill Safety Follow FDA Approval of Generic Version – The Monitor

This volume shares findings from the KFF/The Washington Post Survey of Parents about exposure to and trust in children’s health content on social media, along with misleading claims following the approval of a generic version of mifepristone, reports of autism possibly being added to the Vaccine Injury Compensation Program, and patients using AI chatbots to…

Read More

Greg Whisman, Caremore

Greg Whisman is the Chief Medical Officer of Caremore, a venerable prepaid medical group caring for seniors. It’s been part of Anthem/Elevance for many years but this year spun off as part of a larger PE backed group called Millennium. We really got into the what and the how of primary care for seniors and,…

Read More